CRTCE acquired by AltMed Capital

29 April 2020

On April 29, 2020, AltMed Capital Corp. ("AltMed") purchased 100% of the shares of the Canadian Rapid Treatment Centre of Excellence Inc. (“CRTCE”). This transaction was completed in advance of and in anticipation of AltMed’s acquisition by Champignon Brands Inc. which closed the following day.

CRTCE, located in Toronto, provides IV Ketamine Infusion Therapy for the management of psychiatric disorders.

Gowling WLG was counsel to two of the three selling shareholders of CRTCE with a team that included Todd Bissett (corporate), Ash Gupta (tax) and Jodey Theirrault (real estate).


NOT LEGAL ADVICE. Information made available on this website in any form is for information purposes only. It is not, and should not be taken as, legal advice. You should not rely on, or take or fail to take any action based upon this information. Never disregard professional legal advice or delay in seeking legal advice because of something you have read on this website. Gowling WLG professionals will be pleased to discuss resolutions to specific legal concerns you may have.